MGC Diagnostics Corporation
MGCD
MGCD was delisted on the 28th of December, 2017.
0 hedge funds and large institutions have $0 invested in MGC Diagnostics Corporation in 2018 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 12 closing their positions.
100% less funds holding
Funds holding: 12 → 0 (-12)
100% less capital invested
Capital invested by funds: $4.23M → $0 (-$4.23M)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 12
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
KCM
Kennedy Capital Management
St Louis,
Missouri
|
-$2.53M |
| 2 |
KPF
K2 Principal Fund
Toronto,
Ontario, Canada
|
-$578K |
| 3 |
BGIM
Brandywine Global Investment Management
Philadelphia,
Pennsylvania
|
-$488K |
| 4 |
Creative Planning
Overland Park,
Kansas
|
-$395K |
| 5 |
Northern Trust
Chicago,
Illinois
|
-$126K |
MGCD Hedge Fund Activity: Q1 2018 in Review
0 of the 4,363 institutional investors tracked by Wall St. Rank reported a position in MGC Diagnostics Corporation (MGCD) for Q1 2018, worth a combined $0 — down 100% from $4.23M a quarter earlier.
Sellers outnumbered buyers: 12 funds closed out of MGCD and 0 opened new positions — a net loss of 12 holders — while 0 trimmed existing stakes and 0 added.
The largest seller was Kennedy Capital Management, exiting entirely with an estimated $2.53M sold.
- 0 institutional investors held MGC Diagnostics Corporation (MGCD) as of Q1 2018, down from 12 in Q4 2017.
- Funds reported $0 of MGC Diagnostics Corporation stock for Q1 2018, down 100% quarter-over-quarter.
- 0 funds opened new MGC Diagnostics Corporation positions in Q1 2018 and 12 closed out, a net change of -12 holders.
- The largest MGC Diagnostics Corporation seller in Q1 2018 was Kennedy Capital Management, an estimated $2.53M sold.
Based on aggregated 13F filings for Q1 2018.